Last Updated: October 31, 2019
The Site may collect information from visitors both by asking you specific questions and by permitting you to communicate directly with us via email and/or feedback forms. Some of the information that you submit on the Site may be Personal Information. A site may further use “cookies” and Internet Protocol (“IP”) addresses. A cookie is a bit of information that a website sends to your web browser that helps the site remember information about you and your preferences and an IP address is a number assigned to your computer by your Internet service provider. The IP address can be used to diagnose problems with a server, report aggregate information, determine the fastest route for your computer to use in connecting to a site, and administer and improve the site. Please read more here: https://www.valneva.com/en/legal/cookie-policy. Please note that if you wish to subscribe and connect your personal social media account to our Site, e.g. if you would like to share information on your own social media account, certain Personal Information will be shared with us such as Personal Information linked to your profile or your friends profiles on the applicable social media account.
Pharmacovigilance is the process of discovering, evaluating, understanding and preventing adverse reactions or other problems related to medicines. Their notification is of great importance for public health. We will only use and share this information for pharmacovigilance purposes. This processing is necessary for compliance with a legal obligation to which Valneva is subject. Valneva is required to store and report information relevant to pharmacovigilance to health authorities worldwide. The reports contain detailed information on the incident, but only to a limited extent personal data. With regard to patients, the notification will contain, if available, only age, date of birth, year of birth, gender and initials, depending on the information available, but never the name of the patient. With regard to the notifier, the notification will include, depending on the information available, the name, professional activity (e.g. doctor, pharmacist), address, e-mail address and telephone number. The contact details are necessary to be able to follow up the reporting and thus obtain high-quality and complete information on adverse events.
We will not use your Personal Information for marketing activities unless you have consented to receive marketing communications from us. Based either on consent or, when applicable, on the fulfilment of contractual obligations, we will store your name, contact details and your position within your company being a vendor, customer or other business partner.
If you would like to access your Personal Information or get it rectified or updated please contact us at the address below. You also have the right to withdraw your consent at any time and we will stop any future use of your Personal Information (unless there is a legal obligation that prevents us from doing so). Authorised employees, agents and representatives of Valneva who require access to your Personal Information in order to fulfil their job requirements will have access to your Personal Information.
You may contact us by writing to us at the following address:
Valneva Canada Inc., 600-3535, Saint-Charles Blvd. Kirkland (Montreal), Quebec, H9H 5B9
You may also contact Valneva`s Data Protection Officer at: email@example.com
NOTE: If you are a physician or other health care professional and would like to record an adverse event, please contact firstname.lastname@example.org
If you have any comments or complaints regarding the way your Personal Information is being handled, you have the right to contact the Office of the Privacy Commissioner of Canada.
Click the Cancel button to return to www.dukoralcanada.com or OK to continue.